{"id":1036421,"date":"2012-07-24T19:10:31","date_gmt":"2012-07-24T19:10:31","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/plandai-biotechnology-inc-receives-5-6-million-initial-funding-from-the-land-and-agriculture-bank-of-south-africa.php"},"modified":"2024-08-17T15:56:16","modified_gmt":"2024-08-17T19:56:16","slug":"plandai-biotechnology-inc-receives-5-6-million-initial-funding-from-the-land-and-agriculture-bank-of-south-africa","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/plandai-biotechnology-inc-receives-5-6-million-initial-funding-from-the-land-and-agriculture-bank-of-south-africa.php","title":{"rendered":"Plandai Biotechnology, Inc. Receives $5.6 Million Initial Funding From the Land and Agriculture Bank of South Africa"},"content":{"rendered":"<p><p>    SEATTLE, July 24, 2012 (GLOBE NEWSWIRE) -- Plandai    Biotechnology, Inc. (PLPL)    a producer of highly bioavailable plant extracts, today    announced that it has received the funds from the initial draw    down on the 100 million Rand (US $13 million) loan from the    Land and Agriculture Bank of South Africa. The total amount of    the first draw was 49 million Rand (approx. $5.6 million USD).  <\/p>\n<p>    Plandai Chairman and Chief Executive Officer, Roger Duffield,    commented, \"This initial draw is the first step in moving    towards full-scale production of our highly bioavailable    botanical extracts. These funds will allow us to complete the    engineering of the plant and equipment and acquire the    necessary components so that we can be operational in the 2013-    2014 tea season. Further drawdowns will provide the necessary    investment to rejuvenate and operate the Senteeko Tea Estate as    a modern and efficient farming enterprise that will produce    high levels of polyphenolic catechin in quality green tea leaf    l.\" Mr. Duffield continued; \"Our daily expected processing    output from the processing of live green tea leaf should yield    between 400 -600 kg of extract; and during the dormant tea    growing period, the extraction facility has the flexibility to    be utilized to recover valuable bioflavonoids and limonoids    from citrus fruits, giving the processing facility the ability    to operate all year round.\"  <\/p>\n<p>    Several epidemiological studies have shown beneficial effects    of green tea in cancer, cardiovascular, and neurological    diseases. The health benefits associated with green tea    consumption have also been corroborated in animal studies of    cancer chemoprevention, hypercholesterolemia, atherosclerosis,    Parkinson's disease, Alzheimer's disease, and other    aging-related disorders. However, the use of current green tea    and green tea extracts as a cancer preventive or for other    health benefits has been confounded by the low oral    bioavailability of its active polyphenolic catechins,    particularly epigallocatechin-3-gallate (EGCG).  <\/p>\n<p>    The proprietary CRS hydrodynamic system developed by Plandai    releases antioxidants that are recovered in the process in a    form more readily absorbable in human tissue.  <\/p>\n<p>    The Land and Agriculture Bank of South Africa (<a href=\"http:\/\/www.landbank.co.za\/\" rel=\"nofollow\">http:\/\/www.landbank.co.za\/<\/a>) is a specialist    agricultural bank guided by a government mandate to provide    financial services to the commercial farming sector and to    agri-business and to facilitate access to finance by new    entrants to agriculture from historically disadvantaged    backgrounds.  <\/p>\n<p>    About Plandai Biotechnology, Inc.  <\/p>\n<p>    Plandai Biotechnology, Inc. focuses on the farming of whole    fruits, vegetables and live plant material and the production    of proprietary functional foods and botanical extracts for the    health and wellness industry. Its principle holdings consist of    land, farms and infrastructure in South Africa. Web site:        <a href=\"http:\/\/www.plandaibiotech.com\/\" rel=\"nofollow\">http:\/\/www.plandaibiotech.com\/<\/a>  <\/p>\n<p>    Safe Harbor Statement  <\/p>\n<p>    The information provided may contain forward-looking statements    and involve risks and uncertainties. Results, events and    performances could vary from those contemplated. These    statements involve risks and uncertainties which may cause    actual results, expressed or implied, to differ from predicted    outcomes. Risks and uncertainties include product demand,    market competition, and Plandai's ability to meet current or    future plans. Investors should study and understand all risks    before making an investment decision. Readers are recommended    not to place undue reliance on forward-looking statements or    information. Plandai is not obliged to publicly release    revisions to any forward-looking statement, to reflect events    or circumstances afterward, or to disclose unanticipated    occurrences, except as required under applicable laws.  <\/p>\n<\/p>\n<p>Link:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/plandai-biotechnology-inc-receives-5-133000742.html;_ylt=A2KJNTsW8w5QSUEArUv_wgt.\" title=\"Plandai Biotechnology, Inc. Receives $5.6 Million Initial Funding From the Land and Agriculture Bank of South Africa\" rel=\"noopener\">Plandai Biotechnology, Inc. Receives $5.6 Million Initial Funding From the Land and Agriculture Bank of South Africa<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> SEATTLE, July 24, 2012 (GLOBE NEWSWIRE) -- Plandai Biotechnology, Inc. (PLPL) a producer of highly bioavailable plant extracts, today announced that it has received the funds from the initial draw down on the 100 million Rand (US $13 million) loan from the Land and Agriculture Bank of South Africa. The total amount of the first draw was 49 million Rand (approx.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/plandai-biotechnology-inc-receives-5-6-million-initial-funding-from-the-land-and-agriculture-bank-of-south-africa.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-1036421","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036421"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1036421"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036421\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1036421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1036421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1036421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}